RIPK1 and central nervous system cancer: In this context, Zhou J et al. used Nec-1 and GSK872 to inhibit RIPK1 and RIPK3, respectively, and demonstrated that necroptosis is the critical death mechanism induced by emodin, an anthraquinone compound with antitumor activities, in the U251 glioma cell line [27].